How Analysts Rated Quidel Corporation (NASDAQ:QDEL) Last Week?

May 26, 2018 - By Peter Erickson

Investors sentiment decreased to 1.17 in Q4 2017. Its down 0.03, from 1.2 in 2017Q3. It dropped, as 18 investors sold Quidel Corporation shares while 35 reduced holdings. 27 funds opened positions while 35 raised stakes. 30.94 million shares or 0.83% more from 30.68 million shares in 2017Q3 were reported.
The Germany-based Deutsche Bankshares Ag has invested 0% in Quidel Corporation (NASDAQ:QDEL). York Management Advisors Ltd Llc holds 0.13% in Quidel Corporation (NASDAQ:QDEL) or 120,371 shares. Barclays Public Limited Com stated it has 6,172 shares. Cannell Peter B And owns 408,800 shares. Northern Tru holds 368,192 shares or 0% of its portfolio. Teton accumulated 147,061 shares. Credit Suisse Ag accumulated 32,070 shares or 0% of the stock. Eam Investors Limited Liability Corporation reported 45,737 shares. Obermeyer Wood Invest Counsel Lllp holds 20,891 shares. Grp Incorporated One Trading L P invested in 4,000 shares or 0% of the stock. Geode Capital Mngmt Limited Company invested 0.01% of its portfolio in Quidel Corporation (NASDAQ:QDEL). Tiaa Cref Investment Mgmt Limited Liability Corporation owns 109,520 shares for 0% of their portfolio. Td Asset Incorporated stated it has 42,084 shares or 0% of all its holdings. First Light Asset Mgmt Ltd Liability Company invested in 1.43% or 119,901 shares. Dupont Capital Mngmt Corp stated it has 31,111 shares or 0.03% of all its holdings.

Since December 8, 2017, it had 0 insider purchases, and 10 sales for $15.81 million activity. $1.86M worth of stock was sold by BRYANT DOUGLAS C on Tuesday, March 27. 12,000 Quidel Corporation (NASDAQ:QDEL) shares with value of $582,031 were sold by SCHULER JACK W. 16,358 shares were sold by Kroll Werner, worth $661,529. The insider Bujarski Robert Joseph sold $4.40M. $1.46M worth of stock was sold by STEWARD RANDALL J on Tuesday, December 12.

Quidel Corporation (NASDAQ:QDEL) Ratings Coverage

Among 8 analysts covering Quidel Corp (NASDAQ:QDEL), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Quidel Corp has $6400 highest and $52.0 lowest target. $59.80’s average target is -2.29% below currents $61.2 stock price. Quidel Corp had 11 analyst reports since December 21, 2017 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, January 4 by CL King. The firm earned “Buy” rating on Friday, April 13 by William Blair. Piper Jaffray maintained the stock with “Buy” rating in Tuesday, April 3 report. Barclays Capital maintained Quidel Corporation (NASDAQ:QDEL) on Monday, January 22 with “Buy” rating. On Thursday, March 8 the stock rating was upgraded by Raymond James to “Strong Buy”. The stock of Quidel Corporation (NASDAQ:QDEL) earned “Buy” rating by C.L. King on Thursday, January 4. The stock of Quidel Corporation (NASDAQ:QDEL) earned “Buy” rating by Canaccord Genuity on Tuesday, January 2. Canaccord Genuity maintained the shares of QDEL in report on Thursday, April 5 with “Buy” rating. The stock of Quidel Corporation (NASDAQ:QDEL) earned “Overweight” rating by Barclays Capital on Monday, April 2. The firm has “Buy” rating by Canaccord Genuity given on Thursday, December 21. Below is a list of Quidel Corporation (NASDAQ:QDEL) latest ratings and price target changes.

13/04/2018 Broker: William Blair Rating: Buy Maintain
05/04/2018 Broker: Canaccord Genuity Rating: Buy New Target: $64.0000 Maintain
03/04/2018 Broker: Piper Jaffray Rating: Buy New Target: $63.0000 Maintain
02/04/2018 Broker: Barclays Capital Old Rating: Overweight New Rating: Overweight Old Target: $60 New Target: $63 Maintain
26/03/2018 Broker: Craig Hallum Rating: Buy New Target: $62.0000 Initiate
08/03/2018 Broker: Raymond James Old Rating: Outperform New Rating: Strong Buy Old Target: $47 Upgrade
22/01/2018 Broker: Barclays Capital Rating: Buy New Target: $60.0 Maintain
04/01/2018 Broker: CL King Old Rating: Neutral New Rating: Buy Upgrade
04/01/2018 Broker: C.L. King Rating: Buy Upgrade
02/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $52.0 Maintain

The stock decreased 1.13% or $0.7 during the last trading session, reaching $61.2. About 263,123 shares traded. Quidel Corporation (NASDAQ:QDEL) has risen 128.16% since May 26, 2017 and is uptrending. It has outperformed by 116.61% the S&P500.

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications primarily in infectious diseases, POC womenÂ’s and general health, and gastrointestinal diseases. The company has market cap of $2.29 billion. The firm offers Sofia influenza A+B and QuickVue influenza tests to detect viral antigens of influenza type A and B; Sofia strep A fluorescent immunoassay and QuickVue Strep A tests to detect group A Streptococcal antigen from throat swabs; and Sofia Respiratory Syncytial Virus , QuickVue RSV, and Quidel Molecular RSV + human metapneumovirus tests for respiratory syncytial virus. It currently has negative earnings. It also provides various products to detect various herpes simplex virus (HSV) and herpes family viruses; H&V-Mix to isolate HSV, VZV, and Cytomegalovirus; R-Mix to detect Influenza A and B, RSV, Adenovirus, and Parainfluenza types 1, 2, and 3; Sofia S.

More news for Quidel Corporation (NASDAQ:QDEL) were recently published by: Businesswire.com, which released: “Quidel to Present at UBS Global Healthcare Conference” on May 15, 2018. Seekingalpha.com‘s article titled: “Quidel’s (QDEL) CEO Doug Bryant on Q1 2018 Results – Earnings Call Transcript” and published on May 09, 2018 is yet another important article.

Quidel Corporation (NASDAQ:QDEL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: